Stock News

Real-time ticker analysis, price-action alerts, and institutional-grade stock data.

XPOF
$7.50+11.11%
4/6, 8:00 PM

Xponential Fitness, Inc. Initiates Review of Strategic Alternatives to Maximize Shareholder Value

IRVINE, Calif.--(BUSINESS WIRE)--Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”), one of the leading global franchisors of boutique health and wellness brands, today announced its Board of Directors has initiated a review of strategic alternatives to maximize shareholder value. As part of this process, the Board's independent directors will evaluate a range of potential alternatives, which may include a sale of the Company, a merger, or another strategic or financial trans.

businesswire.comView Stock
ACP
$5.96+15.95%
4/6, 7:58 PM

ACP Holdings Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

HOUSTON, TX, April 06, 2026 (GLOBE NEWSWIRE) -- ACP Holdings Acquisition Corp. (the “Company”) today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to commence trading on April 7, 2026 on the Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “ACGCU.”

globenewswire.comView Stock
ORGO
$2.83+26.34%
4/6, 7:02 PM

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the completion of a randomized controlled trial (RCT) evaluating PuraPly®AM plus standard of care (SOC) versus SOC alone in the management of non-healing diabetic foot ulcers (DFUs).

globenewswire.comView Stock
REAL-TIME FEEDTERMINAL PAGE 9